investors.hypovereinsbank.de
HypoVereinsbank / Investor Relations
Skip over generic navigation. Skip over primary navigation. IR Releases and Präsentationen. Herzlich willkommen auf unserer Investor Relations Homepage. Hier finden Sie Informationen zu unseren Zahlen, Ratings, Emissionen, Präsentationen und vieles mehr. HypoVereinsbank mit starkem operativen Ergebnis. Weitere Informationen finden Sie hier. Ergebnisse and Halbjahresfinanzbericht zum 30. Juni 2015. Können Sie hier downloaden. Ergebnisse and Zwischenbericht zum 31. März 2015. Können Sie hier downloaden.
investors.idealsettlements.com
Life Settlement Investments
If you’ve never invested money into life insurance policies there is likelihood you have questions regarding this asset class. The questions that are most important to investors include security of the investment, return on investment, and stability of the fund. Consider the following prior to investing with a company:. Is the company transparent throughout the whole process. Can preferred policies be funded. Average median and compounded ROI. Do you have the ability to diversify your investment portfolio.
investors.idhcorp.com
About Us – IDH
Skip to main content. IDH (Integrated Diagnostics Holdings). To provide the highest quality and most efficient medical laboratory services at reasonable prices. To maintain and even enhance our business credibility, and the trust we have gained through our industrious endeavor to become the best and most reliable medical laboratory services in Egypt and the Middle East. Integrated Diagnostics Holdings plc. The Company's registered and head office is at 12 Castle Street, St Helier, Jersey JE2 3RT.
investors.ididata.com
Interactive Data | IDI
160; 0.10. Data as of Aug 18, 2015 2:05 pm ET. IDI, Inc. is an information solutions provider focused on the multi-billion dollar data-fusion market. IDI delivers otherwise unattainable insight into the ever-expanding universe of consumer- and business-centric data. Aug 14, 2015. IDI, Inc. Reports Second Quarter 2015 Results. Jul 24, 2015. IDI, Inc. Announces $10 Million Registered Direct Offering. Jul 08, 2015. IDI, Inc. Launches idiBASIC Information Solution Offering. Jul 02, 2015. Aug 17, 2015.
investors.idoxgroup.com
Idox plc - Investors home
Jump to main navigation. Engineering Information Management Software. Board committees and Director responsibilities. Idox Companies Statutory Information. Idox group is a supplier of software solutions and services to the UK public sector and increasingly to the wider corporate sector. LSE: Idox plc profile. IDOX Annual Report 2017. Published 27 March 2018. IDOX PLC - Notice of Annual General Meeting. Published 27 March 2018. Idox plc - Proxy AGM2018. Published 27 March 2018. Holding(s) in Company,.
investors.illegalburgerco.com
Illegal Burger Investors | Just another WordPress site
Investors Email Sign up Here. Want to learn how you can invest directly with Illegal Burger? Looking to become a franchisee? Enter your Email Below and one of our Investor Relations Associates will be in touch. Investor Information and Contact. Our future growth plan incorporates our own corporate location growth as well as Franchise growth; therefore boosting the profit margin and introducing a new commercial base of business that would be untapped up to this point for us.
investors.impacthomes.com.au
Investor Login - Impact Homes
IHub gives you 24/7 direct online access to financial reports and business updates for the Impact Group AUS. V20161.1.1 [2016.1.1.1].
investors.impaxlabs.com
Impax Laboratories, Inc. - Investor Relations
Skip to main content. Quarterly and Other Reports. Executive Officers and Directors. Pricing delayed 20 minutes. Review the latest results, trading conditions and financial reports. View upcoming events and latest presentations. March 1, 2017. Opens in new window). February 28, 2017. Opens in new window). Get answers to important investor relations questions. Get answers to your investor relations questions. Get answers to important investor relation questions. Impax Laboratories, Inc. Powered By Q4 Inc.
investors.impellam.com
Impellam | Overview
Our vision is to be the world`s most trusted staffing company - trusted by our people, our customers and our investors in equal measure. View our board members. Delayed by at least 15 minutes. View detailed share price. Oversees the Group’s internal risk and controls strategy, including whistleblowing arrangements. Reviews the Annual Report and interim financial statements prior to submission to the full Board. Reviews reports from external auditor. Reviews the Group’s risk register. Lord Ashcroft KCMG PC.
investors.imperva.com
Imperva | Investors | Corporate Governance
Nominating and Corporate Governance Committee. Whistleblower and Complaint Policy. Code of Business Conduct and Ethics. Committee Structure and Composition. Below is a summary of our committee structure and membership information. Nominating and Corporate Governance Committee. Stockholder correspondence should be mailed to:. College Station, TX 77842-3170. Overnight correspondence should be sent to:. 211 Quality Circle, Suite 210. College Station, TX 77845. Http:/ www.computershare.com/investor.
investors.imuc.com
Investor Relations - ImmunoCellular
April 14, 2015 - CEO Andrew Gengos interview with The Wall Street Analyzer. August 13, 2015. ImmunoCellular Therapeutics Reaches Agreement with FDA on Special Protocol Assessment (SPA) for ICT-107 Phase 3 Registrational Trial in Glioblastoma. August 6, 2015. ImmunoCellular Therapeutics Announces Second Quarter 2015 Financial Results. View all press releases ». August 6, 2015 at 2:00 PM PT. ImmunoCellular Therapeutics Second Quarter 2015 Financial Results. July 8, 2015 at 2:30 PM ET.
SOCIAL ENGAGEMENT